Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. 9504-9504
DOI: 10.1200/jco.2018.36.15_suppl.9504
Links
Tools
Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma.
Journal article published in 2018 by
Reinhard Dummer,
Paolo Antonio Ascierto,
Helen Gogas,
Ana M. Arance,
Mario Mandalà,
Gabriella Liszkay,
Claus Garbe,
Dirk Schadendorf,
Ivana Krajsova,
Ralf Gutzmer,
Vanna Chiarion-Sileni 
,
Caroline Dutriaux,
Jan Willem de Groot,
Naoya Yamazaki,
Carmen Loquai
and other authors.
,
Caroline Dutriaux,
Jan Willem de Groot,
Naoya Yamazaki,
Carmen Loquai
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 